Biobusiness Development Grants Awarded

Biobusiness grants help develop Minnesota businesses and infrastructure to deliver regenerative medicine products and services. Learn more about how to apply for a biobusiness grant by reading our frequently asked questions. 

 

View bio business grants awarded by year.
Wesley Wierson, PhD
Completing infrastructure needs for scaled manufacturing and deployment of regenerative cell therapies
LEAH Lab’s mission is to identify cell therapy treatments in dogs that, due to lower regulatory requirements and reduced costs, can eventually be…
2023 - 2024
Patrick Walsh, MS
Expanding Anatomic Infrastructure for Scaling Manufacturing Operations
Anatomic, a University of Minnesota start-up company based in Minnesota, develops neural tissues used in basic science and drug development. Its…
2024-2026
image (8).png
Diana Trujillo, PhD
Commercialization of Placental Alkaline Phosphatase (PLAP) for Regeneration of Skin Tissue for Many Fields of Use
Our goal with this grant is to push innovation to increase yield and lower production cost for targeted proteins, using molecular farming. Reducing…
2022-2023
wierson headshot (1) cropped.jpeg
Wesley Wierson, PhD
Enhancing Infrastructure for Development and Analysis of Regenerative Cell Therapies
LEAH Labs is an innovative biotech startup headquartered at Mayo Clinic's 'Hatchery Lab' developing regenerative cell therapies, first focused on…
2022-2023
_DSC9359 cropped.jpeg
Richard Murphy
Development of a peripheral nerve wrap using regenerative engineering tissue tube
This project aims to develop and implant a preclinical model of a regenerative tissue tube for nerve repair. The TRUE™ Tissue allogeneic biomaterial…
2022-2023
RKD Proefessional Picture.jpeg
Ross Dunbar
Liquid Nitrogen-Free Cryogenic Storage System
1) Build and test a customer demonstration model of the liquid nitrogen-free cryogenic storage system. This system will allow storage and…
2022-2023
Athanasiou
Maria Athanasiou, PhD
Regenerative Medicine for the Durable Remission of HIV, Analytical Testing Infrastructure
We are developing a one-time treatment for durable remission of HIV, after which patients will no longer need to take traditional antiretroviral…
2022-2023
Robert Kaiser
Robert Kaiser, PhD, DABT
Isolation of primary human hepatocytes for expansion in a bioincubator
To procure and optimize processing of human hepatocytes for research and clinical purposes.
2021-2022
Andrew Lewis
Andrew Lewis, PhD
Allogeneic platform for regenerative cell therapy by non-viral gene knockdown
The goal of this project is develop a platform for engineering cells from non-autologous sources for cell therapy. We will use a transposon-based non…
2021-2022
Picture of Timothy O'Brien, DVM, PhD
Timothy O'Brien, DVM, PhD
Pre-Clinical Development of an Organoid-Derived Exosome Product for Treatment of Osteoarthritis
Our goal is to develop a therapeutic product that can arrest or reverse the progress of osteoarthritis of the knee, delay or obviate the need for…
2021-2022
Vanesa Alonso-Camino, PhD
Vanesa Alonso-Camino, PhD
Performance of a viral clearance study for the development and characterization of a pathogen reduced human platelet lysate to safely and efficiently expand therapeutic stem cells
The central goal of this proposal is to conduct a viral clearance validation study. To meet the growing demand of pathogen reduced hPL used in…
2021-2022
Patrick Walsh, MS
Patrick Walsh, MS
Scaling Anatomic Facilities for Sustained Success
This proposal will expand Anatomic facilities through equipment purchases to establish an independent laboratory. This will create room for…
2021-2022